CGNS.F Stock Overview
Cognetivity Neurosciences Ltd. operates as a technology company.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cognetivity Neurosciences Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.012 |
52 Week High | CA$0.27 |
52 Week Low | CA$0.01 |
Beta | -0.38 |
1 Month Change | -7.82% |
3 Month Change | -32.34% |
1 Year Change | -94.74% |
3 Year Change | -97.56% |
5 Year Change | -95.34% |
Change since IPO | -96.50% |
Recent News & Updates
Recent updates
Shareholder Returns
CGNS.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | -32.3% | 1.4% | 1.2% |
1Y | -94.7% | -0.7% | 24.7% |
Return vs Industry: CGNS.F underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: CGNS.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
CGNS.F volatility | |
---|---|
CGNS.F Average Weekly Movement | 44.8% |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CGNS.F's share price has been volatile over the past 3 months.
Volatility Over Time: CGNS.F's weekly volatility has increased from 32% to 45% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Sina Habibi | cognetivity.com |
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. Fundamentals Summary
CGNS.F fundamental statistics | |
---|---|
Market cap | US$1.03m |
Earnings (TTM) | -US$6.32m |
Revenue (TTM) | US$72.37k |
18.9x
P/S Ratio-0.2x
P/E RatioIs CGNS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CGNS.F income statement (TTM) | |
---|---|
Revenue | CA$98.97k |
Cost of Revenue | CA$1.36m |
Gross Profit | -CA$1.27m |
Other Expenses | CA$7.38m |
Earnings | -CA$8.64m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.092 |
Gross Margin | -1,278.71% |
Net Profit Margin | -8,732.77% |
Debt/Equity Ratio | -19.9% |
How did CGNS.F perform over the long term?
See historical performance and comparison